Stem cell therapy has become an integral piece in the search for an innovative method to treat both Type 1 and Type 2 Diabetes, as the push to move away from regular insulin injections for patients continues. Mesenchymal stem cells’ ability to morph or differentiate into different types of cells in the body makes them a strong candidate to combat the condition that affects hundreds of millions of people worldwide.
Mesenchymal stem cells (MSCs) innately migrate toward areas of inflammation. Research shows that when administered intravenously, mesenchymal stem cells cross the blood-brain barrier leading to various therapeutic effects.
Stem cells are undifferentiated cells that can become multiple types of cells and reproduce continuously. There are two major types of stem cells: mesenchymal and embryonic. Mesenchymal stem cells have been shown potential to be useful in therapeutic procedures to treat diseases such as Alzheimer’s, kidney disease, cancer, and osteoarthritis. As stem cell therapy has become more popular and reliable, many myths and pieces of misinformation have arisen surrounding it.
Stem cells are undifferentiated cells which are defined by their ability to become multiple types of cells and their ability to proliferate indefinitely. Two of the most commonly talked about types of stem cells are mesenchymal and embryonic.
INTRODUCTION: Neurologic diseases are some of the most dreaded in existence. Like most human afflictions many of them involve inflammatory changes. For this reason stem cell treatment, which is anti-inflammatory, has shown excellent promise in treating a significant number of the most feared neurologic disorders. Often times immunosuppressive drugs are used for treatment. However these drugs have a high side effects profile. In contrast stem cell treatment has no significant side effects.
